Table 1.
Demographic and clinical characteristics of Filipino patients with GO
| Variable | Inactive N=150 | Active N=13 | N=163 |
|---|---|---|---|
| Age (years) | 35 ± 11 | 38 ± 16 | 35 ± 11.45 |
| Male Sex | 26 (17%) | 5 (38%) | 31 (19%) |
| Menarche earlier than age 15 years (N=132) | 100 (81%) | 6 (75%) | 106 (80%) |
| Menopause at age ≥51 years (N=17) | 6 (38%) | 0 | 6 (35%) |
| Oral contraceptive use (N=132) | 42 (34%) | 2 (25%) | 44 (33%) |
| Household monthly income* (in PhP) | 9418 ± 8332 | 6269 ± 9162 | 8000 (3000-12000) |
| Disease duration (months)* | 47 ± 48 | 28 ± 34 | 24 (12-60) |
| ATD used | |||
| Propylthiouracil | 16 (11%) | 0 | 16 (10%) |
| Methimazole | 130 (87%) | 13 (100%) | 143 (88%) |
| Carbimazole | 4 (3%) | 0 | 4 (2%) |
| Duration of ATD treatment (months)* | 30 ± 40 | 19 ± 16 | 12 (4-36) |
| History of thyroid storm | 18 (12%) | 2 (15%) | 20 (12%) |
| Glucocorticoid use | 4 (3%) | 3 (23%) | 7 (4%) |
| Current or past smoker | 47 (31%) | 4 (31%) | 51 (31%) |
| History of allergy or atopy | 29 (19%) | 2 (15%) | 31 (19%) |
| Presence of other comorbid illness | 30 (20%) | 5 (38%) | 35 (21%) |
| Family history of thyroid disease | 75 (50%) | 10 (77%) | 85 (52%) |
| FT4 (pmol/L)* | 30 ± 25 | 25 ± 12 | 19.82 (13.30-38.98) |
| TRAb (U/L)* | 21 ± 28 | 51 ± 32 | 8.9 (1.7-40) |
| UIE (mcg/L)* | 216 ± 175 | 209 ± 185 | 171 (82-288) |
Values are expressed as mean + SD, frequency (%)
*
Median (interquartile range)